NCT00237614View on ClinicalTrials.gov

Contrast Nephropathy Prevention With N-Acetylcysteine in Acute Myocardial Infarction

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

February 28, 2003

Study Completion Date

May 31, 2005

Conditions
Contrast-Induced NephropathyAcute Myocardial Infarction
Interventions
DRUG

intravenous and oral N-acetylcysteine

Trial Locations (1)

20138

Centro Cardiologico Monzino, Milan

All Listed Sponsors
lead

University of Milan

OTHER

NCT00237614 - Contrast Nephropathy Prevention With N-Acetylcysteine in Acute Myocardial Infarction | Biotech Hunter | Biotech Hunter